University College London Hospital
About University College London Hospital
University College Hospital is a teaching hospital in the Fitzrovia area of the London Borough of Camden, England. The hospital, which was founded as the North London Hospital in 1834, is closely associated with University College London, whose main campus is situated next door.
There are 665 beds in University College London Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University College, London
139
University College London Hospitals
29
Hoffmann-La Roche
28
Janssen Research & Development, LLC
24
European Organisation for Research and Treatment of Cancer - EORTC
17
Pfizer
15
Celgene
12
University of Birmingham
12
Queen Mary University of London
11
Daiichi Sankyo, Inc.
10
Institute of Cancer Research, United Kingdom
10
Clinical Trials at University College London Hospital
During the past decade, University College London Hospital conducted 471 clinical trials. In the 10-year time frame, 471 clinical trials started and 114 clinical trials were completed, i.e. on
average, 24.2% percent of trials that started reached the finish line to date. In the past 5 years, 166 clinical trials started and 70 clinical trials were completed. i.e. 42.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjuvant Radiation Therapy in Treating Patients With Brain Metastases
1996-11-01
Terminated
340
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
1998-04-01
2005-07-01
Completed
800
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
1997-12-01
2009-03-01
Completed
45
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
1998-09-01
Completed
704
Combination Chemotherapy in Treating Men With Germ Cell Cancer
1998-10-01
Unknown status
498
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University College London Hospital" #1 sponsor was "University College, London" with 139 trials, followed by "University College London Hospitals" with 29 trials
sponsored, "Hoffmann-La Roche" with 28 trials sponsored, "Janssen Research & Development, LLC" with 24 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC"
with 24 trials sponsored. Other sponsors include 497 different institutions and
companies that sponsored additional 259 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University College London Hospital"
#1 collaborator was "Cancer Research UK" with 44 trials as a collaborator, "University College London Hospitals" with 41 trials as a collaborator, "AstraZeneca" with 24 trials as a collaborator, "University College, London" with 16 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 12 trials as a collaborator. Other collaborators include 618 different institutions and companies that were
collaborators in the rest 379 trials.
Clinical Trials Conditions at University College London Hospital
According to Clinical.Site data, the most researched conditions in "University College London Hospital" are
"Prostate Cancer" (40 trials), "Ovarian Cancer" (25 trials), "Multiple Myeloma" (21 trials), "Breast Cancer" (20 trials) and "Fallopian Tube Cancer" (15 trials). Many other conditions were trialed in "University College London Hospital" in a lesser frequency.
Clinical Trials Intervention Types at University College London Hospital
Most popular intervention types in "University College London Hospital" are "Drug" (474 trials), "Other" (102 trials), "Procedure" (83 trials), "Biological" (69 trials) and "Device" (57 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (72 trials), "Cyclophosphamide" (19 trials), "Gemcitabine" (17 trials), "Dexamethasone" (16 trials) and "quality-of-life assessment" (16 trials). Other intervention names were less common.
Clinical Trials Genders at University College London Hospital
The vast majority of trials in "University College London Hospital" are
600 trials for "All" genders, 70 trials for "Male" genders and 69 trials for "Female" genders.
Clinical Trials Status at University College London Hospital
Currently, there are 304 active trials in "University College London Hospital".
8 are not yet recruiting,
162 are recruiting,
126 are Active, not recruiting,
and 8 are Enrolling by invitation.
In total, there were 266 completed trials in University College London Hospital,
5 suspended trials,
and 59 terminated clinical trials to date.
Out of the total trials that were conducted in University College London Hospital, 127 "Phase 1"
clinical trials were conducted, 277 "Phase 2" clinical
trials and 204 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 14 trials, and there were
also 98 trials that are defined as “Not Applicable".
Departments of University College London Hospital
University College London Hospital has several departments that took part in Clinical trials: "The Heart Hospital" - 14 trials, "National Hospital for Neurology and Neurosurgery" - 85 trials, "UCLH Cancer Clinical Trials Unit" - 5 trials, "University College Hospital Macmillan Cancer Centre" - 4 trials, "Royal National Throat, Nose & Ear Hospital" - 3 trials, "Gastrointestinal Physiology Unit, University College London Hospital" - 2 trials, "University College Hospital; Department of Oncology" - 2 trials, "UCLH - Clinical Trials Pharmacy B&D Centre" - 2 trials
Departments List
Name
City
Trials